Search Press releases

Press releases teaser image
25 Apr 2024

UCB’s General Meeting of Shareholders 2024

Read More
Press releases teaser image
25 Apr 2024

UCB off to a Good Start into 2024 – Progressing on its Growth Path for a Decade Plus

Read More
Press releases teaser image
23 Apr 2024

Transparency notification FMR LLC

Read More
Press releases teaser image
22 Apr 2024

UCB receives European Commission approval for BIMZELX[®]▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa

Read More
Press releases teaser image
19 Apr 2024

Acquisition of own shares

Read More
Press releases teaser image
17 Apr 2024

FINTEPLA[®]▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe